Medicalgorithmics (LTS:0QR8) EPS (Basic): zł-0.97 (TTM As of Mar. 2026)


LTS:0QR8 Medicalgorithmics SA LTS:0QR8
72 GF Score
Price zł33.07
GF Value zł30.84
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics EPS (Basic)?

Medicalgorithmics LTS:0QR8 72 EPS (Basic) is zł-0.97 as of Mar. 2026. GuruFocus rates LTS:0QR8 with a GF Score™ of 72/100 and a GF Value™ of zł30.84. The stock has 4 warning signs investors should review.

Medicalgorithmics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was zł-0.22. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.97.

Medicalgorithmics's EPS (Diluted) for the three months ended in Mar. 2026 was zł-0.22. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.97.

Medicalgorithmics's EPS without NRI for the three months ended in Mar. 2026 was zł-0.22. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.86.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Medicalgorithmics's highest 3-Year average EPS without NRI Growth Rate was 73.20% per year. The lowest was -51.20% per year. And the median was 23.25% per year.

Medicalgorithmics  (LTS:0QR8) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medicalgorithmics EPS (Basic) Related Terms

Medicalgorithmics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Medicalgorithmics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics EPS (Basic) Chart

Medicalgorithmics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.73 -2.08 -0.06 -1.62 -1.17

Medicalgorithmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 -0.25 -0.41 -0.09 -0.22
LTS:0QR8
72GF Score
Medicalgorithmics SA LTS:0QR8
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicalgorithmics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medicalgorithmics's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-11.684-0)/9.953
=-1.17

Medicalgorithmics's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-2.148-0)/9.953
=-0.22

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of zł-0.97 mean?
Medicalgorithmics (LTS:0QR8) has a EPS (Basic) of zł-0.97 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medicalgorithmics and its competitors.
Is Medicalgorithmics' EPS (Basic) too high?
Medicalgorithmics' current EPS (Basic) is zł-0.97. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' EPS (Basic) compare to ABT and SYK?
Medicalgorithmics' EPS (Basic) of zł-0.97 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medicalgorithmics and its competitors. Medicalgorithmics's current EPS (Basic) is zł-0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (LTS:0QR8) has a current EPS (Basic) of zł-0.97. The stock's GF Value™ is zł30.84, compared to a current price of zł33.07 — trading 7.2% above its estimated fair value. The current EPS (Basic) is zł-0.97. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Medicalgorithmics (LTS:0QR8), the current EPS (Basic) is zł-0.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicalgorithmics (LTS:0QR8) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be overvalued. The current stock price of zł33.07 is trading 7.2% above its estimated GF Value™ of zł30.84.

Key valuation signals for LTS:0QR8:

  • EPS (Basic): zł-0.97
  • GF Value™: zł30.84 vs. price of zł33.07 (7.2% above fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the LTS:0QR8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicalgorithmics Business Description

Other Exchanges MDG:Poland
Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score

Get the complete analysis for LTS:0QR8

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł33.07
Price
zł30.84
GF Value